Asabys Partners
Venture capitalMadrid · Seed–Growth · 18 people tracked
Investment thesis
Asabys focuses on pushing the boundaries of science and medicine to improve patients' lives, backing highly innovative and transformative technologies. The firm positions itself as a hands-on partner and collaborator to its portfolio companies. It integrates environmental, social, and governance considerations into its investment processes and aligns its practices with the United Nations Sustainable Development Goals. Asabys is financially backed by the EU under the EFSI established through the Investment Plan for Europe.
Source: firm website, verified Aug 3, 2026.
Team · 18 people
from the firm's website & curatedWhat they invest in
from 25 of 32 portfolio companiesHealthtech ×17Medical Devices ×13Biotech ×11Digital Health ×10AI & Machine Learning ×6Deep Tech ×6Fintech ×1Hardware ×1
HQs:Spain×8Belgium×1France×1Israel×1
Investments · 32 tracked
founders shown can be your intro pathBy year:2025 · 22021 · 13 dated
SafeHeal is a medical device manufacturer developing anastomosis protection devices for colorectal surgery.
BiotechDigital HealthHealthtechMedical DevicesFrance, FR
Chris Richardson(President & CEO)Karl Blohm(VP, International)inScott DePierro(VP, US Operations)inMarcos Velez-Duran(VP, Regulatory Affairs and Quality)inBrent Metzler(CFO)Michael Augelli(VP, R&D, Manufacturing)in
Co-investorsSofinnova Partners
SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.
BiotechDeep TechDigital HealthBarcelona, ES
Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)
Co-investorsNovartis Venture FundRoche Venture FundSanofi VenturesYsios CapitalCriteria Bio VenturesNew Enterprise Associates (NEA)+2 more
Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases.
BiotechHealthtech
Laurent Nguyen(CEO)inPablo Villoslada(CSO)inRossella Medori(CMO)inPaul Bikard(CFO)in
Co-investorsAliath BioventuresKinled Holding
Agomab is a clinical-stage biopharmaceutical company developing disease-modifying therapies for fibro-inflammatory and fibrotic diseases with high unmet medical need.
BiotechHealthtechMedical DevicesAntwerp, BE
Tim Knotnerus(Chief Executive Officer)
Co-investorsEQT Life SciencesAdBio partnersAndera PartnersCanaan PartnersPontifax Venture CapitalV-Bio Ventures+1 more
XRHealth provides telehealth therapy delivered at home using FDA-registered VR/AR headsets, mobile apps, wearables, and prescription digital therapeutics (such as Stanza), combined with licensed clinicians.
Digital HealthHealthtechMedical Devices
Anaconda Biomed develops neurovascular medical devices, including the ANA funnel-based aspiration catheter, for endovascular treatment of acute ischemic stroke from large vessel occlusion, such as mechanical thrombectomy.
HardwareHealthtechMedical DevicesBarcelona, ES
Co-investorsYsios CapitalEuropean Investment BankInnogest Capital
Augustine Therapeutics is a biotech company developing HDAC6-targeted therapies for peripheral neuropathies such as Charcot-Marie-Tooth disease and chemotherapy-induced peripheral neuropathy, as well as neurodegenerative disorders like ALS.
BiotechMedical Devices
Co-investorsAdBio partnersJeito CapitalNovo HoldingsPMVV-Bio Ventures
HealthtechTrowbridge
Stanley Lapidus(Director)Andrew Goldman(Director)Anna Dixon(Executive Officer)Martin Munchbach(Director)Jihua Wang(Director)Joachim Rothe(Director)
Deepull develops a multiplex PCR diagnostic system to rapidly identify sepsis-causing pathogens and antibiotic resistance markers directly from blood samples in approximately one hour, targeting hospitals and clinical laboratories.
Medical Devices
Co-investorsColumbus Venture Partners
Valuat provides software for managing investment operations, serving fund managers, investors, and founders.
FintechSaaS
Co-investorsNazca Capital S.G.E.I.C,Swanlaab Venture Factory
Co-investorsSofinnova Partners
Gradient develops the Gradient Denervation System, a minimally invasive, ultrasound-based catheter platform that ablates nerves around the pulmonary artery (pulmonary artery denervation) to treat patients with pulmonary hypertension, including those with pulmonary hypertension due to left heart disease.
HealthtechMedical Devices
Inbiomotion develops the MAF Test, a biomarker diagnostic based on MAF gene expression that helps doctors select early breast cancer patients for adjuvant bisphosphonate treatment.
BiotechDigital HealthMedical Devices
Co-investorsCriteria Bio VenturesYsios CapitalAlta Life Sciences
INBRAIN Neuroelectronics develops graphene-based brain-computer therapeutics that combine neural signal decoding with AI to enable precision, adaptive treatments for neurological disorders.
AI & Machine LearningDeep TechMedical DevicesBarcelona, ES
Carolina Aguilar(CEO & Co-Founder)Kostas Kostarelos(Chair of the Vision Board & Co-Founder)Antòn Guimerà(Co-founder)Jerome Crocco(COO)Jurriaan Bakker(CTO)Eduard Ros(Interim CFO)
Co-investorsBStartupVsquared VenturesAliath Bioventuresimec.xpand
Koa Health develops a unified digital mental health platform that delivers evidence-based treatment programs and clinical interventions.
Digital HealthHealthtechMental Health
Oliver Harrison(Chief Executive Officer)
Co-investorsBeresford VenturesCREAS IMPACTO GLOBAL SGEICMundi VenturesWessel Management
Medasense develops a noninvasive sensor platform and AI technology for objective pain measurement, helping clinicians personalize pain management and avoid overmedication.
AI & Machine LearningDigital HealthHealthtechMedical DevicesRamat Gan, IL
Galit Zuckerman-Stark(Founder and CEO)
Co-investorsOTV
binx health develops point-of-care molecular diagnostic solutions, including the FDA-cleared, CLIA-waived binx io platform that tests for chlamydia and gonorrhea with results in 30 minutes.
Digital HealthHealthtechMedical Devices
Co-investorsOrbiMed
Nuage develops drug discovery technology targeting intrinsically disordered proteins in cancer, focusing on oncogenic transcription factors previously inaccessible to conventional drug discovery approaches.
AI & Machine LearningBiotechDeep Tech
Co-investorsBStartupSofinnova Partners
Ona Therapeutics is a biotechnology company developing first-in-class antibody drug conjugates (ADCs) and antibody therapies targeting the molecular biology of treatment-refractory advanced cancers.
BiotechHealthtech
Co-investorsFund+KorysMérieux Equity PartnersYsios CapitalAlta Life SciencesBpifrance+2 more
Orikine Bio develops precision-engineered bi-specific cytokine therapies ("Foldikines") that reprogram immune signaling to treat severe autoimmune and inflammatory diseases.
BiotechDeep TechHealthtechBarcelona, ES
BoardLarry Edwards(Chairman of the Board)
Co-investorsAdBio partners
Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials.
BiotechDeep TechHealthtechMedical DevicesBarcelona, ES
Dr. Laura Soucek(Co-founder and CEO)Dr. Marie-Eve Beaulieu(Co-founder)Laura Soucek(Co-founder & CSO (former CEO))
Co-investorsAurora ScienceInvivo Capital Partners
Qida provides in-home care services for elderly and dependent people in Spain, matching families with professional caregivers on a flexible basis (from one hour a week to live-in 24/7 care) with ongoing supervision by psychologists or social workers.
Digital HealthHealthtechLongevitySabadell, ES
Oriol Fuertes Cabassa(Founder)in
Co-investorsBStartupCREAS IMPACTO GLOBAL SGEICKibo VenturesMundi VenturesShip2BEndeavor Catalyst+2 more
Quibim develops cloud-based AI software platforms for medical imaging analysis that extract radiomics features and generate predictive models for healthcare providers and biopharma companies.
AI & Machine LearningHealthtechMedical Devices
Co-investorsAdara VenturesAmadeus Capital PartnersLifeX VenturesAPEX VenturesColumbus Venture PartnersGoHub Ventures
Sidekick Health develops a digital health platform for multi-chronic condition management and personalized care experiences, delivering patient education and lifestyle support for conditions such as IBD, rheumatoid arthritis, and dermatological disease.
Digital HealthHealthtechWellness & Fitness
Co-investorsFrumtak Ventures
XR therapeutics platform company that merged with Amelia Virtual Care.
Co-investors20/20 HealthCare Partners LLCBridges IsraelFlying Tiger Capital
Portfolio news
latest coverage across their companies
Ona Therapeutics · fiercebiotech.com · Aug 12, 2026
Agomab Therapeutics · investing.com · Aug 10, 2026
INBRAIN Neuroelectronics · newmarketpitch.com · Jul 13, 2026
Qida · eldercareoutlook.com · Nov 10, 2025
Deepull · cuatrecasas.com · Apr 30, 2025
Frequently asked questions
- How many investments has Asabys Partners made?
- Asabys Partners has 20 tracked investments, including 1 dated in the last 24 months.
- What stage does Asabys Partners invest at?
- Asabys Partners invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Asabys Partners focus on?
- Asabys Partners focuses on Biotech, Deep Tech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is Asabys Partners located?
- Asabys Partners is headquartered in Madrid, ES.
- Does Asabys Partners lead rounds?
- Asabys Partners typically participates in rounds rather than leading them.
- Who does Asabys Partners co-invest with?
- Asabys Partners most often shares deals with BStartup, AdBio partners, Ship2B, among 19 tracked co-investors.
Media · Podcasts & interviews
featuring the teamClara Campàs comenta la misión de Asabys Partners
Crónica Global · Clara Campàs
#LifeAfterCovid: Clara Campàs (Asabys Partners), entrevista completa
Capital Cell · Clara Campàs
Co-investors · 1
Ysios Capital is a life sciences investor that finances innovative biotech companies worldwide, providing resources to develop novel therapies for indications with high unmet medical needs.
Firms observed investing alongside Asabys Partners, from public investor directories. Shared companies are the overlap with Asabys Partners's recorded portfolio.
Similar investors
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
MaRS is a Toronto-based innovation hub and accelerator that supports Canadian startups from pre-seed funding through international expansion, offering workspace, mentorship, investor and customer connections, and sector-focused programming.
BDC Fund Investments is the fund-of-funds arm of BDC Capital that acts as a limited partner, backing emerging and established fund managers who invest in technology-focused Canadian companies.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.


































